| Price | 1.49 |
| Price Change Today | -$0.07 (-4.49%) |
| P&P rating | ![]() |
| Zacks Rank | 2 - BUY |
| Open Price | $1.57 |
| Previous Close | $1.56 |
| Daily Range | $1.48 - $1.58 |
| 52-Week Range | $1.10 - $2.33 |
| Volume | 164,242 |
| Dyax Corp is a biopharmaceutical company that has developed and patented a method that is used to identify a broad range of compounds with potential for the treatment and diagnosis of diseases. The company is also using this method to identify compounds that could be used in purifying and manufacturing biopharmaceuticals and other chemicals. The company's phage display technology to rapidly and cost-effectively determine the potential medical uses of newly discovered proteins and genes and subsequently discover biopharmaceutical product candidates. | |





Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment